Dealmaking is still an important and necessary means for companies to access innovation and sustain revenues in their therapeutic areas of focus. This paper presents an analysis of deal activity of the top 30 companies as ranked by sales in 2017 in IQVIA Analytics Link covering a 5-year period between 2013 and 2017.